How to treat patients with systemic amyloid light chain amyloidosis? Comparison of high-dose melphalan, low-dose chemotherapy and no chemotherapy in patients with or without cardiac amyloidosis.

Clinical and Experimental Nephrology

Volumn 15, Issue 4, 2011, Pages 486-492

  Hoshino, Junichi ^a   Ubara, Yoshifumi ^a   Sawa, Naoki ^a   Sumida, Keiichi ^a   Hiramatsu, Rikako ^a   Hasegawa, Eiko ^a   Suwabe, Tatsuya ^a   Hayami, Noriko ^a   Yamanouchi, Masayuki ^a   Takemoto, Fumi ^b   Taniguchi, Shuichi ^a   Takaichi, Kenmei ^a  

^a TORANOMON HOSPITAL   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Melphalan; Prognosis; Systemic AL amyloidosis; Treatment; VAD

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISOLONE; VINCRISTINE;

ADULT; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEART AMYLOIDOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC AMYLOID LIGHT CHAIN AMYLOIDOSIS; TREATMENT OUTCOME;

ADULT; AGED; AMYLOIDOSIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; COMBINED MODALITY THERAPY; DEXAMETHASONE; DOXORUBICIN; FEMALE; HEART DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER DISEASES; MALE; MELPHALAN; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; VINCRISTINE;

EID: 80054732007     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0426-0     Document Type: Article

References (12)

1. Kyle RA, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45-59 (Pubitemid 24370135)
2. Falk RH, Comenzo RL, Skinner M. The systemic amyloidosis. N Engl J Med. 1997;337:898-909
3. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, et al. The clinical features of immunoglobulin lightchain (AL) amyloidosis with heart involvement. QJM. 1998;91: 141-57 (Pubitemid 28102667)
4. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, et al. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997;336:1202-7 (Pubitemid 27183649)
5. Levy Y, Belghiti-Deprez D, Sobel A. Treatment of AL amyloidosis without myeloma. Ann Med Int Paris. 1988;139:190-3
6. Dispenzieri A, Kyle RA, Lacy MQ, Therneau TM, Larson DR, Plevak MF, et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: A case-control study. Blood. 2004;103:3960-3 (Pubitemid 38596319)
7. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study. Ann Int Med. 2004;140:85-93
8. Shimojima Y, Matsuda M, Ishii W, Koyama J, Yamamoto K, Shimodaira S, et al. High-dose melphalan followed by autologous stem cell support in primary systemic AL amyloidosis with multiple organ involvement. Int Med. 2005;44:484-9 (Pubitemid 40895108)
9. Hoshino J, Ubara Y, Ohashi K, Takemoto F, Takaichi K. Pathologic improvement after high-dose melphalan and autologous stem cell transplantation for primary systemic amyloidosis. NDT Plus. 2008;6:414-6
10. Jaccard A, Moreau P, Leblond V, Leleu X, Benboubker L, Hermine O, et al. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med. 2007; 357(11):1083-93 (Pubitemid 47443213)
11. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol. 2005;79:319-28 (Pubitemid 41098849)
12. Wardley AM, Jayson GC, Goldsmith DJ, Venning MC, Ackrill P, Scarffe JH. The treatment of nephritic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone. Br J Cancer. 1998;78:774-6. (Pubitemid 28418312)